Sep 12, 2023 / 04:55PM GMT
Erin Elizabeth Wilson Wright - Morgan Stanley, Research Division - Equity Analyst
Hi. Good afternoon, everybody. My name is Erin Wright. I'm lead healthcare services analyst at Morgan Stanley. We're happy to have with us today, Zoetis, a leader in Animal Health. The CFO with us today, Wetteny Joseph.
We also have IR in the audience as well to help support to. Just for quick disclosures, please see our Morgan Stanley research website, morganstanley.com/researchdisclosures. If you have any questions, please reach out to your relevant sales representative at Morgan Stanley. And with that, I think we'll just kick it off and get right into Q&A, if that works.
Questions and Answers:
Erin Elizabeth Wilson Wright - Morgan Stanley, Research Division - Equity AnalystSo I think I will start a little bit with kind of guidance and what you gave in the most recent quarter and thinking about it more from an operational perspective at first and how you're thinking about the second half, but the 6% to 8%, how should we be thinking about the cadence from the